IONS•benzinga•
Ionis Announces FDA Acceptance Of New Drug Application For Donidalorsen, Aiming For First-In-Class RNA-Targeted Treatment For Hereditary Angioedema; PDUFA Date Set For August 21, 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 4, 2024 by benzinga